Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

45.00p
   
  • Change Today:
    -2.50p
  • 52 Week High: 96.00
  • 52 Week Low: 37.50
  • Currency: UK Pounds
  • Shares Issued: 26.01m
  • Volume: 1,500
  • Market Cap: 11.71m
  • RiskGrade: 464
  • Beta: 0.01

FAB Overview

Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.

1 Day Chart (06-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -27.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.4 n/a
Pr/Book 3.2  
Latest F'cast
Revenue 11314.9% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

FAB Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 2.69 (0.71) (4.30)p n/a n/a n/a n/a 0.0%
31-Mar-19 2.18 (1.50) (5.70)p n/a n/a n/a n/a 0.0%
31-Mar-20 3.90 (1.07) (3.20)p n/a n/a n/a n/a 0.0%
31-Mar-21 4.16 (1.26) (0.12)p n/a n/a n/a n/a 0.0%
31-Mar-22 4.80 (1.33) (4.60)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

FAB Company Announcements

Second Price Monitoring Extn 09-Jan-2023 16:40 RNS
Price Monitoring Extension 09-Jan-2023 16:35 RNS
Second Price Monitoring Extn 09-Jan-2023 14:05 RNS

Latest FAB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

FAB Market Data

Currency UK Pounds
Share Price 45.00p
Change Today -2.50p
% Change -5.26 %
52 Week High 96.00
52 Week Low 37.50
Volume 1,500
Shares Issued 26.01m
Market Cap 11.71m
Beta 0.01
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.83% below the market average33.83% below the market average33.83% below the market average33.83% below the market average33.83% below the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average
Price Trend
85.83% below the market average85.83% below the market average85.83% below the market average85.83% below the market average85.83% below the market average
74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average
Income Not Available
Growth
71.43% above the market average71.43% above the market average71.43% above the market average71.43% above the market average71.43% above the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average

FAB Dividends

No dividends found

Trades for 06-Feb-2023

Time Volume / Share Price
16:08 1,500 @ 45.00p

FAB Key Personnel

Chair Simon Gordon Douglas
CFO James Alexander Fair
CEO Adrian Kinkaid

Top of Page